Skip to content

Comparison of the effects of local ozone and corticosteroid injection in the treatment of adhesive capsulitis of the shoulder

Comparison of local ozone injection vs corticosteroid injection in the treatment of shoulder adhesive capsulitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100127003217N14
Enrollment
40
Registered
2022-11-09
Start date
2022-11-22
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive capsulitis of the shoulder. Adhesive capsulitis of shoulder

Interventions

Intervention 1: Intervention group:The first intervention group: Ozone with a concentration of 15 micro-gram in the shoulder joint area, blindly and with a posterior approach. Intervention 2: Interven

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 20 years Diagnosis of shoulder adhesive capsulitis based on specialized shoulder tests such as active and passive ROM Pain intensity based on VAS criteria is greater than or equal to 4 Consent to enter the study

Exclusion criteria

Exclusion criteria: Drug addiction History of coagulation disorders, rheumatological diseases, History of intra-articular injection during the previous three months Use of anticoagulants Hypersensitivity reaction to lidocaine Neck radiculopathy Cellulitis and skin infection at the site of intra-articular injection Contraindications for ozone therapy include known cases of G6PD deficiency, uncontrolled hyperthyroidism, pregnancy, and leukemia

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Before the intervention, 2 weeks and 8 weeks after the treatment. Method of measurement: Visual analogue scale (VAS).

Secondary

MeasureTime frame
Shoulder joint range of motion. Timepoint: Before the intervention, 2 weeks and 8 weeks after the treatment. Method of measurement: Goniometry.;Functional disability of shoulder-related activities. Timepoint: Before the intervention, 2 weeks and 8 weeks after the treatment. Method of measurement: Shoulder Pain and Disability Index (SPADI).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Eslamiyan

Tabriz University of Medical Sciences

eslamiyanf@tbzmed.ac.ir+98 41 3337 3967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026